Received Jul 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | — | — |
Patient Took First Dose On 12/6/2024, Is It Too Late For The Second Dose?; Initial report received on 16-Jun-2025. A pharmacist reported that a patient (age, gender, race, ethnicity not reported) received HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization but has not received the second dose yet. No medical history or concomitant medication were reported. On 06-Dec-2024, the patient received dose 1 of a hepatitis B HEPLISAV-B (Lot #, expiration date, NDC #, route, and site not available). At the time of this report, the patient has not received the second dose yet. No additional information was provided. Reporter did not give consent to contact them for additional data. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.